´ºÒ¹Ï²ÓêĿ¼×îÐÂÕ½Ú_´ºÒ¹Ï²ÓêÈ«ÎÄÃâ·ÑÔĶÁ_é¶ÜÎÄÑ§Íø"/> ĸÇ×È¥ÊÀºó£¬ÎÞÊýýÌå×·Îʹ¬ÔóÀí»Ý£º¶Ô²îµã»ÙÁËËýÒ»ÉúµÄĸÇ×£¬ºÞÂð£¿"/>
¡¶´ºÒ¹Ï²ÓêĿ¼×îÐÂÕ½Ú_´ºÒ¹Ï²ÓêÈ«ÎÄÃâ·ÑÔĶÁ_é¶ÜÎÄÑ§Íø¡·¾çÇé¼ò½é£ºÄ¸Ç×È¥ÊÀºóÎÞÊýýÌå×·Îʹ¬ÔóÀí»Ý£º¶Ô²îµã»ÙÁËËýÒ»ÉúµÄĸÇ׺ÞÂð´ºÒ¹Ï²ÓêĿ¼×îÐÂÕ½Ú_´ºÒ¹Ï²ÓêÈ«ÎÄÃâ·ÑÔĶÁ_é¶ÜÎÄÑ§Íø12.Zhu J., Zhang Y., Shi L., Xia Y., Zha H., Li H., Song Z. RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-kappaB signaling pathways. Int. Immunopharmacol. 2022;109:108904.
¡¶´ºÒ¹Ï²ÓêĿ¼×îÐÂÕ½Ú_´ºÒ¹Ï²ÓêÈ«ÎÄÃâ·ÑÔĶÁ_é¶ÜÎÄÑ§Íø¡·ÊÓÆµËµÃ÷£ºÊ²Ã´ÕâÊÇʲôȷ¨ÎÒÀúÀ´Ã»Óп´¹ýÔÆÔÆÐ×ÃÍÁ¬ÄÇÓñ¸®Ì«×ÓĽÈÝÊ¿¶¼ÑÛÉñÒ»ÌøÔÚËûµÄÍ«¿×Ö®Öм±ËÙµÄÍÆËãÆðÀ´ÏëÒª°Ñ·½º®µÄÉñÈÑÝËã͸³¹¿úÊÓµ½Ò»Ë¿Ðþ»ú¹Å×°Íø¾ç¡¶º£»èÐС·9ÔÂ23ÈÕ¾ÙÐпª»úÒÇʽÌÚѶÊÓÆµÈ«Íø¶À²¥¾ç¼¯ÓÉé×Ó¿¡¡¢»ÆÈÕÓ¨¡¢¹¢ÒµÍ¥¡¢³Âæ¾ýÁìÏÎÖ÷ÑÝ3¡¢±¦ÂíÍ˳ö¼ÛǮսºóÐøÌìÏÂ¶àµØ 4S µê±»ÆØ¾Ü²»½»³µ¡¢ÔÝʱ¼Ó¼Û 3 ÍòÔª
2025-10-13 09:56:00